Manabu Seino

Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells

Keita Shibuya, Masashi Okada, Shuhei Suzuki et al. · Oncotarget · 2014 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +17

JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells

Shuhei Suzuki, Masashi Okada, Keita Shibuya et al. · Oncotarget · 2014 · 94 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation

Masashi Okada, Keita Shibuya, Atsushi Satō et al. · Oncotarget · 2014 · 74 citations · Full text

Medicine, Cancer Biology, Oncology +17

The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>

Masashi Okada, Kenta Kuramoto, Hiroyuki Takeda et al. · Oncotarget · 2016 · 59 citations · Full text

Medicine, Oncology, Pharmacology +11

xCT inhibitor sulfasalazine depletes paclitaxel‑resistant tumor cells through ferroptosis in uterine serous carcinoma

Akiko Sugiyama, Tsuyoshi Ohta, Miyuki Obata et al. · Oncology Letters · 2020 · 59 citations · Full text

Medicine, Oncology, Pharmacology +14